Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Atogepant","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=atogepant","facts":[{"label":"Active ingredient \/ generic name","value":"atogepant"}]},{"title":"Rifcap 300 mg Kaps\u00fcl (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=rifcap-300-mg-kapsul","facts":[{"label":"Active ingredient \/ generic name","value":"Rifampisin"},{"label":"ATC code","value":"J04AB02"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed SPL version 19; effective 2025-09-30; retrieved 2026-11-04"}],"sources":[{"label":"QULIPTA (atogepant) \u2014 US prescribing information, DailyMed","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=8c8ab8f4-32bd-497a-befa-70c8a51d8d52"},{"label":"FDA: clinical examples of drugs interacting with CYP enzymes and transporter systems","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:34679","available":true}}